+49 9632/ 9248 325
info@biovariance.de
facebook twitter xing linked in
Logo
  • Products & Services
    • For
      Pharma
    • For
      Physicians
    • For
      Patients
  • Technology
    • Pillbox
    • OncoVariant
  • News
    • Events
    • Blog
  • About Us
    • Company Overview
    • Team
    • History
  • Career
  • de
  • en
here
  • Products & Services
    • For
      Pharma
    • For
      Physicians
    • For
      Patients
  • Technology
    • Pillbox
    • OncoVariant
  • News
    • Events
    • Blog
  • About Us
    • Company Overview
    • Team
    • History
  • Career
  • de
  • en

Press releases

BioinformaticsCancerDiseasesMedicinePersonalizedMedicinePress releasesProjectsScience AreaSoftware DevelopmentUncategorized

TubeLab facilitates laboratory routine

Puplished: 2. July 2020

Waldsassen – BioVariance finishes the development of TubeLab, a software for the organisation of multi-level laboratory processes. To ensure an effective performance of the workflow, TubeLab was developed in cooperation with a renowned diagnostics laboratory.

Press releases

pressemitteilung-oncovariant

OncoVariant automates the drug search for oncologists

Puplished: 30. June 2020

Waldsassen – BioVariance has finished the development of the platform OncoVariant for the interpretation of genetic variants in cancer patients. Thereby, the crucial search for suitable drugs is simplified and accelerated significantly.

Press releases

HORIZON 2020 – REVERT

EU project REVERT for personalized colorectal cancer therapie starts

Puplished: 17. February 2020

Waldsassen – BioVariance has received a commitment for the project REVERT from the European Commission as part of HORIZON 2020, the EU framework program for research and innovation.

Press releases

For the research of DIPG across 14 countries

Puplished: 23. August 2019

DIPG (diffuse intrinsic pontine glioma) describes a brain tumor in children for which there exists no cure or positive life-changing treatment. Even if this type of pontine glioma can be classified as “rare diseases”,

Press releases

Pressemitteilungen-press-releases

BioVariance GmbH is again one of the most innovative companies in Germany

Puplished: 28. February 2019

Waldsassen – The statistic portal Statista and the business magazine „brand eins Innovation ist…“ have honored Germany’s most innovative companies for the fourth time.

Press releases

Pressemitteilungen-press-releases

BioVariance GmbH strengthens its capital base with new investors – Cooperation agreement with Oberender AG

Puplished: 16. January 2019

Waldsassen/Munich. BioVariance GmbH, which is located in Waldsassen, took an important strategic step regarding the future orientation of the company by admitting two new partners. At the beginning of the year FlemingEnterprise Holding GmbH,

Press releases

Pressemitteilungen-press-releases

BioVariance GmbH again one of the most innovative companies in Germany

Puplished: 5. March 2018

Waldsassen – The statistics portal “Statista” and the business magazine “brand eins Wissen” have selected Germany’s most innovative companies for the third time.

Press releases

Pressemitteilungen-press-releases

Artificial intelligence to calculate optimal dosage of psychiatric medication

Puplished: 16. October 2017

BioVariace has received a financial grant for a pioneering research project to calculate personalized dosages for psychotherapeutic drugs based on patient´s unique individual genetic biomarkers. The project “Knowledge for personalized medicine in psychiatric application” will be co-funded by the Bavarian Ministry of Economic Affairs and further project partners includes the Institute of Pharmacy of the University of Würzburg as well as the Center for Mental Health of the University Hospital of Würzburg.

Press releases

Pressemitteilungen-press-releases

Big data revolutionizes medication dosing for children

Puplished: 18. September 2015

Waldsassen. BioVariance has developed a new technology that enables a significant improvement of medication dosing for children and thereby addresses a widespread but often overlooked issue faced by pediatricians today.

Press releases

facebook twitter xing linked in

Legal Notice Data Privacy Disclaimer Cookies

Main address
BioVariance GmbH
Konnersreuther Str. 6g
95652 Waldsassen
Tel.: +49 9632/9248325
info@biovariance.com
Keep connected
facebook twitter xing linked in